rhenium has been researched along with Leukemia in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 9 (81.82) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bräuchle, C; Czyz, M; Feil, F; Lesiak-Mieczkowska, K; Lorenz, IP; Sztiller-Sikorska, M; Wallek, AU; Wirth, S; Zernickel, A | 1 |
| Bartkowiak, D; Bunjes, D; Dohr, D; Röttinger, EM; Wennauer, R | 1 |
| Blumstein, N; Buchmann, I; Buck, AK; Bunjes, D; Döhner, H; Glatting, G; Kotzerke, J; Neumaier, B; Reske, SN; Ringhoffer, M; Schauwecker, P; Stilgenbauer, S; von Harsdorf, S; Wiesneth, M; Zenz, T | 1 |
| Bunjes, D; Kotzerke, J; Scheinberg, DA | 1 |
| Buchmann, I; Bunjes, D; Döhner, H; Glatting, G; Reske, SN; Schlenk, RF; Zenz, T | 1 |
| Blumstein, NM; Buck, AK; Bunjes, D; Glatting, G; Kull, T; Neumaier, B; Reske, SN | 1 |
| Bunjes, D; Glatting, G; Kotzerke, J; Neumaier, B; Reske, SN; Seitz, U | 1 |
| Bergmann, L; Bunjes, D; Dohr, D; Duncker, C; Glatting, G; Kotzerke, J; Neumaier, B; Rentschler, M; Reske, SN; Seitz, U | 1 |
| Bergmann, L; Buchmann, I; Buck, A; Bunjes, D; Döhner, H; Glatting, G; Kotzerke, J; Martin, H; Neumaier, B; Reske, SN; Seitz, U | 1 |
| Dietrich, JW; Hermann, S; Hoelzer, D; Klein, SA; Martin, H | 1 |
| Buchmann, I; Buck, A; Bunjes, D; Döhner, H; Glatting, G; Kotzerke, J; Martin, H; Rattat, D; Reske, SN; Seitz, U | 1 |
1 review(s) available for rhenium and Leukemia
| Article | Year |
|---|---|
Radioimmunoconjugates in acute leukemia treatment: the future is radiant.
Topics: Alpha Particles; Antibodies, Monoclonal; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Beta Particles; Cell Adhesion Molecules; Clinical Trials as Topic; Dose-Response Relationship, Radiation; Humans; Immunoconjugates; Leukemia; Leukocyte Common Antigens; Quality Control; Radioimmunotherapy; Radioisotopes; Radiometry; Rhenium; Sialic Acid Binding Ig-like Lectin 3; Stem Cell Transplantation; Yttrium Radioisotopes | 2005 |
5 trial(s) available for rhenium and Leukemia
| Article | Year |
|---|---|
188Re or 90Y-labelled anti-CD66 antibody as part of a dose-reduced conditioning regimen for patients with acute leukaemia or myelodysplastic syndrome over the age of 55: results of a phase I-II study.
Topics: Aged; Antibodies, Monoclonal; Antigens, CD; Antigens, Differentiation; Antilymphocyte Serum; Antineoplastic Agents; Cell Adhesion Molecules; Female; Follow-Up Studies; Hematologic Diseases; Humans; Immunosuppressive Agents; Leukemia; Lymphocyte Depletion; Male; Melphalan; Middle Aged; Myelodysplastic Syndromes; Radioimmunotherapy; Radioisotopes; Radiometry; Rhenium; Stem Cell Transplantation; Survival Rate; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Vidarabine; Yttrium Radioisotopes | 2005 |
Targeted marrow irradiation with radioactively labeled anti-CD66 monoclonal antibody prior to allogeneic stem cell transplantation for patients with leukemia: results of a phase I-II study.
Topics: Adult; Antigens, CD; Bone Marrow; Cell Adhesion Molecules; Hematopoietic Stem Cell Transplantation; Humans; Immunoconjugates; Leukemia; Middle Aged; Radioisotopes; Rhenium; Transplantation Conditioning; Transplantation, Homologous | 2006 |
Preparation and evaluation of the rhenium-188-labelled anti-NCA antigen monoclonal antibody BW 250/183 for radioimmunotherapy of leukaemia.
Topics: Adolescent; Adult; Antibodies, Monoclonal; Antigens, Neoplasm; Cell Adhesion Molecules; Chromatography, High Pressure Liquid; Chromatography, Thin Layer; Female; Flow Cytometry; Humans; Image Interpretation, Computer-Assisted; Injections, Intravenous; Isotope Labeling; Leukemia; Leukocytes; Male; Membrane Glycoproteins; Middle Aged; Quality Control; Radioimmunotherapy; Radioisotopes; Radiometry; Radiopharmaceuticals; Rhenium; Tissue Distribution | 1999 |
Targeted bone marrow irradiation in the conditioning of high-risk leukaemia prior to stem cell transplantation.
Topics: Adolescent; Adult; Antibodies, Monoclonal; Antigens, CD; Bone Marrow; Disease-Free Survival; Female; Hematopoietic Stem Cell Transplantation; Humans; Leukemia; Male; Middle Aged; Radiation Dosage; Radioimmunotherapy; Radioisotopes; Recurrence; Rhenium; Survival Rate; Transplantation Conditioning; Whole-Body Irradiation | 2001 |
Transplantation-related toxicity and acute intestinal graft-versus-host disease after conditioning regimens intensified with Rhenium 188-labeled anti-CD66 monoclonal antibodies.
Topics: Acute Disease; Adult; Antibodies, Monoclonal; Antigens, CD; Antigens, Differentiation; Cell Adhesion Molecules; Female; Graft vs Host Disease; Humans; Leukemia; Male; Middle Aged; Radioimmunotherapy; Rhenium; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome | 2002 |
5 other study(ies) available for rhenium and Leukemia
| Article | Year |
|---|---|
Tautomerization of 2-nitroso-N-arylanilines by coordination as N,N'-chelate ligands to rhenium(I) complexes and the anticancer activity of newly synthesized oximine rhenium(I) complexes against human melanoma and leukemia cells in vitro.
Topics: Aniline Compounds; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Humans; Isomerism; Leukemia; Ligands; Melanoma; Rhenium | 2010 |
Enhanced renal toxicity of total body irradiation combined with radioimmunotherapy.
Topics: Adolescent; Adult; Animals; Creatinine; Dose Fractionation, Radiation; Female; Follow-Up Studies; Graft vs Host Disease; Humans; Kidney; Leukemia; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Middle Aged; Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Radiation Dosage; Radioimmunotherapy; Radioisotopes; Radiotherapy Dosage; Rats; Rhenium; Stem Cell Transplantation; Time Factors; Whole-Body Irradiation | 2003 |
Dosimetry with (188)Re-labelled monoclonal anti-CD66 antibodies. A simplified approach based on a single measurement 3 h p.i.
Topics: Antibodies, Monoclonal; Antigens, CD; Bone Marrow; Cell Adhesion Molecules; Humans; Image Processing, Computer-Assisted; Kidney; Leukemia; Liver; Radioisotopes; Radionuclide Imaging; Rhenium; Sensitivity and Specificity; Spleen; Tissue Distribution | 2006 |
Radioimmunotherapy for the intensification of conditioning before stem cell transplantation: differences in dosimetry and biokinetics of 188Re- and 99mTc-labeled anti-NCA-95 MAbs.
Topics: Adult; Antibodies, Monoclonal; Antigens, Neoplasm; Cell Adhesion Molecules; Female; Hematopoietic Stem Cell Transplantation; Humans; Leukemia; Male; Membrane Glycoproteins; Middle Aged; Phantoms, Imaging; Radioimmunotherapy; Radiometry; Rhenium; Technetium; Tissue Distribution; Transplantation Conditioning | 2000 |
Myeloablative radioimmunotherapy with Re-188-anti-CD66-antibody for conditioning of high-risk leukemia patients prior to stem cell transplantation: biodistribution, biokinetics and immediate toxicities.
Topics: Adolescent; Adult; Antibodies, Monoclonal; Antigens, CD; Antigens, Differentiation; Bone Marrow; Cell Adhesion Molecules; Female; Hematopoietic Stem Cell Transplantation; Humans; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Liver; Lung; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Radiation Dosage; Radioimmunotherapy; Radioisotopes; Radionuclide Imaging; Rhenium; Survival Rate; Tissue Distribution; Transplantation Conditioning | 2002 |